Related Experiment Video
Updated: Sep 19, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Combined percutaneous renal artery denervation and angioplasty: still too early to consider them complementary?
Fortunato Iacovelli1,2, Luigi Salemme3, Rocco Tritto4
1Division of University Cardiology, Cardiothoracic Department, Policlinico University Hospital, Bari.
Insights
Renovascular hypertension treatment with renal artery angioplasty has unpredictable results. Combining renal denervation and angioplasty may offer a synergistic effect for high-risk patients.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Nephrology
Background:
- Renovascular hypertension poses significant cardiovascular risk.
- Percutaneous renal artery transluminal angioplasty (PTRA) alone shows variable clinical outcomes.
- Limited treatment options exist for high-risk patients.
Observation:
- A novel intention-to-treat strategy combining PTRA with percutaneous renal denervation was applied.
- The procedure was performed on a single patient with exceptionally high cardiovascular risk.
- This represents the first reported case of this combined interventional approach.
Findings:
- The combined percutaneous renal denervation and angioplasty approach was successfully implemented.
- This strategy was explored due to the limitations of PTRA alone in achieving predictable results.
- The synergistic potential of combining these two interventions was investigated.
Implications:
- This case study pioneers a combined interventional approach for complex renovascular hypertension.
- The findings suggest a potential new treatment avenue for high-risk cardiovascular patients.
- Further research is warranted to validate the efficacy and safety of this combined strategy.
Abstract:
In case of renovascular hypertension, percutaneous renal artery transluminal angioplasty alone is still far from demonstrating predictable clinical results. Assuming a potential synergistic effect, we reported the first case of combined percutaneous renal denervation and angioplasty as intention-to-treat strategy in a very high cardiovascular risk patient.
More Related Videos
09:02A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Imaging Studies VII: Vascular Imaging
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Angina IV: Management